Due to physiological metabolic adaptations, blood pressure (BP) during pregnancy undergoes changes. A widely accepted hypothesis establishes that in normal pregnancies a decrease in both systolic BP (SBP) and diastolic BP (DBP) occurs up to mid-pregnancy (i.e., 18-24 weeks) followed by a progressive increase after that, reaching prepregnancy levels during the third trimester. This theory derives from the earliest studies on BP changes during pregnancy, which described the so-called "mid-trimester drop, " 1,2 and had been often confirmed by many others. [3] [4] [5] [6] It became an almost undisputed concept, underlying investigations of hypertensive disorders of pregnancy: being applied in clinical practice, 6 evoked as the basis for screening tests for preeclampsia, 7 and even used as a normal pattern against which pregnancy-induced hypertension may be defined. 8 However, this milestone of the obstetric knowledge has been questioned by a recent well-conducted and thoughtprovoking article, in which Nama et al. 9 present data indicating a progressive increase in BP from the beginning of pregnancy (11-16 weeks) up to the third trimester (34-38 weeks). These results are in line with others from previous studies. [10] [11] [12] Nevertheless, the authors highlighted that their sample was too homogeneous, comprising only white pregnant women, and suggested that studies with more 
heterogeneous populations are needed to confirm their findings. 9 Therefore, we hypothesized that healthy pregnant women drawn from a heterogeneous population might present different patterns of BP change other than the mid-trimester BP drop and that these patterns might be determined by preexisting and pregnancy-related factors. Hence, this study aimed to describe longitudinal changes in SBP and DBP during healthy pregnancies and postpartum, identifying those who followed the classic mid-trimester BP drop pattern and those who did not and to evaluate the influence of socioeconomic, demographic, anthropometric, and physiological factors on the absence of the mid-trimester BP drop.
METHodS
We conducted a prospective cohort of pregnant women in a public health care center in Rio de Janeiro, Brazil. The study comprised 4 follow-up points: 5-13th, 18-26th, 28-39th weeks of gestation, and a fourth visit at 2-9th weeks of postpartum. Women were recruited at the start of prenatal care if they met the following eligibility criteria: <13 weeks of pregnancy, aged between 20 and 40 years, and without any chronic or infectious diseases (except obesity). Enrollment 
Participants and data collection
From 258 women who agreed to participate, 66 were excluded because: >13 weeks pregnant, confirmed later by ultrasound (n = 19); missing BP measures at baseline (n = 5); multiple pregnancy (n = 4); later diagnosis of syphilis (n = 6), HIV (n = 1), hypertension (n = 1), and other chronic or infectious/parasitic disease (n = 4); miscarriage (n = 25); and stillbirth (n = 1). Besides, there were 34 (17.7%) losses to follow-up from the first to second trimester of pregnancy. Thus, for the analyses of longitudinal changes in SBP and DBP, we used data from 158 women who experienced healthy singleton pregnancies. For the analysis of factors associated with the different patterns of mid-trimester BP change, we used data of 152 pregnant women who have no missing information for none of the covariables.
Data collection was conducted by a team of trained and standardized undergraduate and graduate students of health sciences in a quiet and temperature-controlled room. SBP and DBP were measured in duplicate (twice at the baseline with 1 week apart), with an approximate 30-minute interval between the readings, using an automated oscillometric BP monitoring system (Omron HEM-742, São Paulo, Brazil), calibrated prior to study beginning and yearly afterward. The mean values of the duplicate measurements from each follow-up point were used for analysis. Women were comfortably seated for at least 5 minutes with the arm at heart level and palm facing up. The size of the cuff that best fit the upper arm circumference of each woman was chosen before readings. We recorded the outside ambient temperature and categorized this variable as having either an increase or a decrease between the first and second trimester BP measurements as this variable have been reported to affect BP in pregnancy. 13 Gestational age (weeks) was estimated using data from the first ultrasound if it was performed prior to 26 weeks. When this measurement was not available, we used the reported date of the last menstrual period. Baseline body mass index (BMI) was estimated as weight/(height) 2 . Height (m) was measured in duplicate with a portable stadiometer (Seca Ltda., Hamburg, Germany) and the mean value was used for analysis. Weight (kg) was assessed with a digital scale (Filizola Ltda., São Paulo, Brazil). Gestational weight gain (GWG) at each follow-up point was calculated subtracting the weight measured in the previous visit from the current one, and weight gain from the first to the second trimester was classified according to the tertiles of the sample distribution (first: −3.5 to 3.5 kg; second: 3.6-6.0 kg; third: 6.1-16.2 kg).
The following variables (and respective categories) were considered in the analysis: age (20-29; 30-39 years), selfreported skin color (brown/black; white), parity (0; 1; ≥2), family history of hypertension (no; yes), participation in leisure time physical activity before pregnancy (no; yes; defined as a minimum of 150 min per week), baseline smoking status (smoker; nonsmoker), baseline alcohol consumption (no; yes), education (0-8; ≥9 years of study), and monthly percapita family income (tertiles of US$).
Statistical analyses
To investigate the existence of a different pattern in BP change, other than the mid-trimester drop, we stratified the women in 2 groups, independently for SBP and DBP: those who presented a decrease of any magnitude in BP from the first to the second trimester of pregnancy (second trimester BP − first trimester BP < 0) and those who had either no change or an increase in BP levels (second trimester BP − first trimester BP ≥ 0). Comparisons of means between groups were then performed, for each follow-up point, using Student's t-tests for independent samples. Descriptive baseline characteristics for the overall sample and subgroups are presented and comparisons within subgroups were performed using chi-square tests for samples' distribution according to categorical variables. To evaluate the longitudinal differences between trimesters in BP means (for overall sample and subgroups), we performed pairwise comparisons using Student's t-tests and adopted the Bonferroni's correction method for repeated measures (differences were considered statistically significant when P < 0.012). Linear mixed-effects regression models for repeated measures were used to estimate the effect of time in both SBP and DBP changes during pregnancy (for overall sample and subgroups). Time was introduced in the model both as fixed (visit) and as random (gestational age at each visit) terms. Dependencies in the data were handled by an exchangeable structure for the covariance matrix. Additionally, we elaborated scatter plots for both SBP and DBP and their change over time was predicted using the fixed portion of linear mixed-effects models according to the mid-trimester pattern (rise or drop). Lastly, we used Poisson regression models to identify preexisting and pregnancy-related factors associated with no mid-trimester drop in SBP and DBP. Independent variables were tested individually and those for which the estimates achieved a P-value ≤ 0.20 in the univariate models were selected as candidates for the final multivariate models. All models were further adjusted for women's age (in years), baseline SBP and DBP values (in mm Hg), and time between the first and the second measure of BP (in weeks). All statistical analyses were conducted with STATA 10.1 (StataCorp, College Station, TX).
rESuLTS
The majority of the women were between 20 and 29 years old (72.2%), of brown or black skin color (73.4%), non-nulliparous (59.5%), with family history of hypertension (67.8%), nonphysically active before the pregnancy (73.4%), nonsmokers (93%) and nonalcohol consumers (83.5%), with low education level (≤8 years; 60.8%), from families with per-capita income ≤US$ 275 (66.7%), and classified as underweight or normal at baseline (56.3%). Overall, 70/158 (44.3%) and 63/158 (39.9%) of pregnant women showed no mid-trimester SBP and DBP drop, respectively. From the 70 women without the mid-trimester SBP drop, 37.1% of them still presented a mid-trimester DBP drop. White women, with family history of hypertension, that has experienced a decrease in outside ambient temperature between the first and second trimester BP measurement and with higher GWG from the first to second trimester presented higher incidence ratios (IRs) of no mid-trimester drop in SBP (Table 1) .
Mean SBP increased from baseline (106.6 mm Hg) to second trimester (112.2 mm Hg) for women with no midtrimester drop in SBP, reaching an almost steady level until the third trimester (β = 0.251; P < 0.001). Women without a mid-trimester drop in SBP started pregnancy with a significantly lower SBP (106.6 vs. 112.6 mm Hg; P < 0.001), but presented significant higher values in the second trimester (112.2 vs. 104.6; P < 0.001), compared to those who presented a mid-trimester drop in SBP. Women with a mid-trimester drop (β = −0.972; P < 0.001) presented an increase of SBP from second to third trimester (β = 0.019; P < 0.001), with a U-shape variation. The rise in SBP values from the second to the third trimester, observed for both groups, removed the statistical significance of the initial observed difference. Both groups also presented a rise in SBP from the third trimester to the postpartum period ( Figure 1A ,B). Similar patterns were observed for mean DBP values (Figure 2A,B) .
Skin color, family history of hypertension, BMI, change in outside temperature between BP measurements, and GWG were the variables selected in the univariate analysis (P ≤ 0.20) for the final models of mid-trimester drop in SBP and DBP. White skin color (IR: 1.71; 95% confidence interval (CI): 1.22-2.39), family history of hypertension (IR: 1.93; 95% CI: 1.29-2.89), obesity in early pregnancy (IR: 2.29; 95% CI: 1.27-4.11), change in outside temperature between the first and second trimesters (IR: 1.45; 95% CI: 1.00-2.10), and GWG from the first to the second trimester (IR: 1.71; 95% CI: 1.01-2.88) or the third (IR: 2.32; 95% CI: 1.39-3.89) tertiles of the samples' distribution were characteristics associated with absence of mid-trimester drop in SBP. A similar pattern was observed for DBP although the influence of family history of hypertension was weaker and not statistically significant after adjustment in the multivariate model (Table 2 ).
dIScuSSIon
Our study has several interesting findings. First, we observed that not all women who present a mid-trimester drop in SBP follow a similar pattern for DBP. Second, despite the statistically significant differences in SBP and DBP mean values during the first and second trimesters between the "drop" and "no drop" groups, healthy pregnant women evolve to a similar BP outcome by the end of pregnancy and at the postpartum period. Finally, these different patterns of change in BP seem to be determined by both preexisting and pregnancy-related factors, such as skin color, family history of hypertension, early-pregnancy BMI, and GWG from the first to the second trimester.
These results bring new evidence on the process of physiological adaptations in BP during pregnancy. The present study is not the first to suggest the presence of more than 1 pattern of change in BP up to mid-pregnancy. MacdonaldWallis et al. 14 have reported not only that mean values of both SBP and DBP decreased until the 18th week of pregnancy but also that some of the studied women experienced changes in the opposite direction to the overall sample's means. However, differently from previous studies, our approach was to look into the issue of BP changes during pregnancy as a response that depends on individual factors, rather than a unique pattern that all women undergo, unless experiencing some unexpected condition or preceding an adverse outcome.
Indeed, it is speculated that the absence of the mid-trimester drop in BP would be a sign of endothelial dysfunction 12 and there is evidence that it could be predictive of pregnancyinduced hypertension or the development of early-onset of preeclampsia. 15, 16 Nevertheless, in agreement with previous studies, 9, 10 we showed that even in healthy pregnancies, an important percentage of women had progressive elevations in both SBP and DBP from the first trimester onward. Hence, the widespread concept that the absence of the mid-trimester BP drop may be an early indication of increased risk for hypertensive disorders of pregnancy 8 should be faced with caution; moreover, given that both subgroups of women with and without mid-trimester BP drop evolved to similar BP levels at third trimester and at post-partum in healthy uncomplicated pregnancies. However, it is possible that women without a mid-trimester BP drop indeed presented an earlier BP drop, which was captured in the baseline firsttrimester measurements. Indeed, it has been suggested that BP fall may begin at the luteal phase prior to conception and continue until the mid-pregnancy nadir. 17 This possibility cannot be ascertained because prepregnancy BP levels were not measured but seems improbable because the factors we Table 1 . Characteristics of participants, for overall sample and according to patterns of mid-trimester change in systolic and diastolic blood pressure Variables with missing data for some individuals. found associated with absence of mid-trimester BP drop are generally associated with increased BP levels. Furthermore, 37.1% of women who had not presented a mid-trimester SBP drop still had a DBP drop. This means an increase in pulse pressure, which is an indicator of reduced arterial compliance and has been proposed to be a risk factor for preeclampsia when elevated in early pregnancy. 18 Thus, it is reasonable to speculate that presenting a pattern of rise in SBP and drop in DBP might represent an additional risk for hypertensive disorders of pregnancy. Yet, as our sample comprises only healthy pregnancies, we were not able to explore this hypothesis, nor if being part of some of the mid-trimester rise in BP groups (or a combination of these patterns) is associated with any adverse outcome of pregnancy or even future adverse health outcomes (such as an increased risk of developing essential hypertension), so that it remains to be investigated in future studies.
The association of white skin color with a higher IR of no mid-trimester drop in both SBP and DBP reinforces the results from a previous study, 9 in which progressive BP elevations were observed in a sample of Caucasian women. As opposed to the previous study, Grindheim et al., 6 studying a smaller sample (n = 57) of white skin color women, observed a statistically significant drop in both SBP and DBP around 22-24 gestational weeks. Bouthoorn et al. 19 in a sample of 6,215 women of different ethnicities (Dutch, Turkish, Moroccan, Antillean, Surinamese, and Cape Verdean) found that Dutch women have higher SBP and DBP through all trimesters of pregnancy, when compared to their counterparts of different ethnicities. We believe that the differences in the results of the studies might be due to the sample sizes and different methods of ethnicity classification.
Our results are in line with the ones from previous studies showing that women who have first-or second-degree relatives with aggregate cardiovascular risk factors before becoming pregnant were more likely to develop preeclampsia and pregnancy-induced hypertension. 20, 21 Even not including women with hypertensive disorders of pregnancy in our sample, the results from our study corroborates evidence showing that family load represents shared genetic or environmental commonalities carried by a woman into her pregnancy and evidenced by higher BP levels presented even early in the second trimester. 22, 23 The associations of BMI and GWG with BP changes during pregnancy are very well documented. [24] [25] [26] [27] [28] However, the pathways by these factors are positively associated with BP levels during pregnancy are not clear and several explanations have been proposed. It has been suggested that the autonomic function might be diminished in obese women leading to reduced adaptive ability for the pregnancy-related demands. 29 Sympathetic over activity was also suggested to be the mechanism underlying the observed associations. 24, 25, 30 Another hypothesis advocates that the adiposity-related insulin resistance might indirectly influence the adaptive BP response to pregnancy, through endothelial dysfunction and systemic inflammation, 31, 32 which would also explain the association between obesity and preeclampsia. 33 Anyhow, the effects of BMI and GWG on autonomic responsiveness and the BP changes during pregnancy have not been adequately examined yet and further research is necessary to explore the complex mechanisms underlying these relationships.
The possibility that the "regression to the mean" phenomenon may have influenced our results warrants discussion. Several arguments make it unlikely to have markedly affected the results although it cannot ruled out. First, at the study design level, we performed 4 BP measurements at baseline and we used their mean. This prevented the chance of occurrence of extreme spurious BP values. Second, we adjusted all the multivariable analyses of BP changes to their respective baseline values, which is a recognized method to deal with the "regression to the mean" phenomenon. 34 Third, the correlation coefficient between the first and second measurements was relatively high (0.54-0.56), which also decreases the "regression to the mean. " 34 Fourth, there was no regression to the mean between the second and third trimesters, and the third and postpartum BP measurements as all BPs increased between these periods. Lastly, the correlation coefficients between baseline values and absolute differences of SBP and DBP at second and first trimesters were low supporting that there was only a small trend toward higher positive differences for lower BP values at baseline due to possible regression to the mean. Our study has some limitations and the use (and classification) of skin color as a proxy variable to represent race/ ethnicity is clearly an important one. Although skin color has been often used to describe ethnicity, it is probably not the most adequate criterion. On the other hand, there is no consensus on how to evaluate, categorize, and report results related to race/ethnicity in medical research. 35, 36 The adopted classification 37 was recently shown to be as good as a more detailed skin color scale, in the prediction of health-related outcomes for the Brazilian population. 38 Additionally, although the Omron HEM-742 device has been validated in accordance with the international protocol of the European Society of Hypertension for normal subjects, 39 it has not been validated in pregnancy. However, most oscillometric BP devices have been found to be accurate in pregnancy, tending to underestimate BP only in preeclampsia, as a consequence of the pathologic alterations in the vascular system driven by the syndrome. 40 So, we believe that the use of this device has not significantly influenced the results. The relatively small sample of this study is another limitation because this could potentially exaggerate BP differences between women with and without mid-trimester drop. Finally, we did not have out-of-office (ambulatory or home) BP measurements, which provide more accurate estimates of actual BP levels. Otherwise, as we exclude women with initial high BPs, our results were not affected by the "whitecoat effect, " but we cannot account for a possible "masked hypertension effect, " which can only be revealed by out-ofoffice BP measurements. 41 In conclusion, to the best of our knowledge, this is the first study to describe longitudinal changes in SBP and DBP during healthy pregnancies, according to the pattern of BP changes in the mid-trimester. Other studies are needed to confirm our results and to explore genetic and molecular mechanisms behind these patterns. We consider that the major contribution of the present study is a different way to look into the phenomenon of BP changes during pregnancy. While most women seem to present a mid-trimester drop in both SBP and DBP, it is clearly not observed in all pregnancies, even those without any associated adverse outcome. Not all women who present a mid-trimester rise in SBP follow the same pattern for DBP Abbreviations: 95% CI, 95% confidence interval; BMI, body mass index; DBP, diastolic blood pressure; GWG, gestational weight gain; IR, incidence ratio; SBP, systolic blood pressure.
a Further adjusted for age (years), time elapsed between SBP measures (weeks) and baseline SBP and DBP values (mm Hg).
b P values refer to the log-likelihood ratio test.
and that might be reflecting a decrease in arterial compliance. The extent of how the different patterns of mid-trimester BP changes are linked to adverse outcomes remains to be studied. However, it is possible that other hemodynamic measures, such as systemic vascular resistance and arterial compliance, as opposed to arterial pressure, as well as serum biomarkers (inflammatory cytokines, markers of insulin resistance, or endothelial dysfunction), might be better risk markers in pregnancy. Further, as these different patterns are probably determined by both preexisting and early-pregnancy-related characteristics, future investigations and preventive strategies should be planned to start prior to conception.
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